- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
How COVID-19 May Awaken Dormant Breast Cancer Cells? Study Provides Insights - Video
Overview
A new study published in the journal Nature reveals that respiratory viruses such as COVID-19 and influenza can awaken dormant breast cancer cells in the lungs, potentially leading to cancer recurrence years after initial treatment.
Cancer recurrence remains a looming concern for survivors, even after remission. Researchers from Albert Einstein College of Medicine and Utrecht University investigated the impact of viral infections on dormant breast cancer cells—also known as disseminated cancer cells (DCCs)—in mice. These DCCs migrate from the primary tumor to distant organs like the lungs and remain inactive for years. But the study found that respiratory viruses can act as a trigger, reactivating these cells and leading to rapid tumor formation.
In the experiment, mice that had dormant breast cancer cells in their lungs were exposed to either SARS-CoV-2 or influenza. Within just two weeks, the previously resting cells had begun to proliferate, forming visible tumors. Scientists found that inflammation caused by viral infection played a key role. When the immune system fights off infections, it releases signaling proteins to coordinate its response. One of these proteins, interleukin-6, was identified as a major driver behind the reactivation of dormant cancer cells.
To test whether this finding held true in humans, researchers analyzed breast cancer patient databases. They discovered that survivors who contracted respiratory infections had a significantly increased risk of lung metastases within the first year post-infection. These findings align with early pandemic data showing a spike in cancer deaths and metastatic disease among survivors who had contracted COVID-19.
This research highlights the importance of monitoring cancer survivors more closely following respiratory illnesses, especially in the first year after infection.
Reference: Chia, S.B., Johnson, B.J., Hu, J. et al. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature (2025). https://doi.org/10.1038/s41586-025-09332-0